2. Signaling Pathways
  3. Membrane Transporter/Ion Channel
  4. Synaptic Vesicle Proteins
  5. Synaptic Vesicle Proteins Modulator

Synaptic Vesicle Proteins Modulator

Synaptic Vesicle Proteins Modulators (4):

Cat. No. Product Name Effect Purity
  • HY-119810
    Seletracetam
    		Modulator 99.70%
    Seletracetam (Ucb 44212), as an analog of the antiepileptic agent Levetiracetam, is a SV2A modulator for the research of epilepsy.
  • HY-157999
    SDI-118
    		Modulator 98.86%
    SDI-118 is an orally active modulator for synaptic vesicle glycoprotein 2A (SV2A) with an IC50 of 13 nM.
  • HY-180554
    UCB1244283
    		Modulator
    UCB1244283 is a synaptic vesicle glycoprotein 2A (SV2A) allosteric modulator. UCB1244283 binds to a secondary ligand-binding site in SV2A and enhances orthosteric ligand engagement when the orthosteric site is occupied, by stabilizing the occluded state and slowing ligand dissociation. UCB1244283 shows a clear protective effect against both tonic and clonic convulsions in sound-sensitive mice. UCB1244283 can be used for epilepsy research.
  • HY-119810B
    Seletracetam lithium bromide
    		Modulator
    Seletracetam (Ucb 44212) lithium bromide, an analog of the antiepileptic agent Levetiracetam, is a SV2A modulator for the research of epilepsy.